Literature DB >> 1869459

Pancoast tumor: radiation therapy alone versus preoperative radiation therapy and surgery.

C R Neal1, R J Amdur, W M Mendenhall, D G Knauf, A J Block, R R Million.   

Abstract

This is a retrospective analysis of 73 patients with non-oat cell carcinoma of the lung presenting as a Pancoast tumor. All patients were treated with curative intent between October 1964 and September 1987 (minimum follow-up 2 years). The treatment plan consisted of preoperative radiation therapy (usually 3000 cGy in 2 weeks or 4500 cGy in 5 weeks) in 41 patients and radiation therapy alone (usually 6500-7000 cGy in 6.5-8.0 weeks) in 32 patients. In general, radiation therapy alone was reserved for poor-prognosis patients (extensive disease or medical inoperability). Although 41 patients were initially scheduled to receive preoperative radiation therapy and surgery, the surgery was not performed in 12 cases (29%) because of patient refusal (4 patients), poor response to radiation therapy (4 patients), distant metastasis (2 patients), or debilitation (2 patients). Separate calculations were carried out for the patients who completed the surgery as planned (preoperative radiation therapy and surgery) and the entire group originally scheduled for combined-modality therapy. There was no significant difference in the absolute or cause-specific survival rates between treatment groups, but severe complications were significantly more common in patients receiving combined therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1869459     DOI: 10.1016/0360-3016(91)90683-u

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Pancoast tumours: clinical assessment and long-term results of combined radiosurgical treatment.

Authors:  G Muscolino; M Valente; S Andreani
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

2.  Chest wall invasive non-small cell lung cancer: patterns of failure and implications for a revised staging system.

Authors:  D H Harpole; E A Healey; M M DeCamp; S J Mentzer; G M Strauss; D J Sugarbaker
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.